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Abstract 
Purpose: To evaluate cardiopulmonary functional capacity and the production of cytokines in patients 
with and without Chagas disease, and with and without hypertension, after short and long-term 
exercise. 
Methods: In a case-controlled study, 56 participants who attended the Chagas Disease Laboratory at 
the State University of Maringa (LDC/UEM) and Basic Health Units (UBS) in Maringa that agreed to 
participate. The participants were divided into the following groups: 16 with Chagas disease (CHD 
group), 21 with systemic arterial hypertension (SAH group) and 19 normal individuals without these 
morbidities (NI group). Each participant performed the 6-min walk test (6MWT), and a 12-week physical 
training program. Pro-inflammatory and anti-inflammatory cytokines were measured before and after 
physical training. 
Results: The CHD group presented good performance in the 6MWT, with no significant differences in 
distance traveled or perceived exertion (p > 0.05) compared with the NI group. After physical training, 
the 6MWT results were significantly better, with significant decreases in systolic and diastolic blood 
pressure, in the SAH group (p = 0.0409; and p = 0.0377, respectively) and NI group (p = 0.0180; and p 
= 0.0431, respectively) and a significant increase in the levels of the anti-inflammatory cytokine 
interleukin-10 (IL-10; p < 0.05) in all three groups. The NI group exhibited a significant increase (p < 
0.05) in the serum levels of the pro-inflammatory cytokines IL-6, IL-17 and tumor necrosis factor (all p < 
0.05). 
Conclusion: All of the participants presented improvements in cardiopulmonary functional capacity and 
good prognosis, indicating the protective effect of IL-10 production  and the benefits of physical training. 
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Latin America, and specifically, Brazil still have 
many chronic carriers of Chagas disease who 
need proper medical care [1], but these 
individuals face psychosocial barriers for to 
diagnosis, treatment, and disease control, and 
have limited availability of resources or political 
support [1]. Thirty percent of Chagas disease 
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cases present cardiac involvement [2]. Patient’s 
daily work activities can become limited, thus 
contributing to a progressive decline in functional 
capacity and quality of life [3]. In addition to 
manifestations that are inherent to this disease, it 
is also associate with other ailments, including 
systemic arterial hypertension (SAH) and 
diabetes mellitus [4]. 
 
The mechanisms of the pathogenesis of Chagas 
disease are not well understood. There is a direct 
relationship between the persistence of the 
parasite in the host, the host’s immune response, 
and the genetic variability of the host [5]. Among 
the host-related factors, the immune response 
has aroused special interest, with an emphasis 
on the regulatory role of cytokines [6]. 
 
Alternative approaches to intervention, such as 
physical exercise, may increase the functional 
capacity of affected organs and improve the 
quality of life of patients with Chagas disease 
and hypertension. Studies of women with 
Chagas disease [7,8] reported that short-term 
aerobic exercise increased physical exertion 
tolerance [7] and had beneficial effects on 
systolic blood pressure (SBP), diastolic blood 
pressure (DBP)  and heart rate (HR) [8].  
 
Some studies [6,9] have also reported that the 
intensity, duration, and frequency of physical 
activity play a key role in determining immune 
function, which can either increase or decrease 
the response to infection. Long-term physical 
training, in turn, can increase of antiinflammatory 
cytokines, especially interleukin IL-10 and IL-13 
[6]. 
 
Regular moderate-intensity exercise can 
decrease the occurrence of infection and intense 
exercise reduces the susceptibility to infection 
[6], a phenomenon that is related to enhanced 
activity of the inflammatory response. The 
response to exercise in patients with heart 
disease of different etiologies, has been the 
subject of many investigations [10], but 
assessments of cardiopulmonary functional 
capacity and the immune response in individuals 
with Chagas disease are rare. 
 
The 6-min walk test (6MWT) is the most used 
method for evaluating submaximal exertion, 
because of its ability to measure the individual’s 
functional capacity by the simple act of walking. 
The present study investigated the role of 
exercise in the immune response in individuals, 
with Chagas disease compared with individuals 







This study was approved by the Committee for 
Ethics in Research with Human Beings at State 
University of Maringa (CAAE 0397.0.093.000-
10), and international guidelines for human 
studies were followed [11]. The participants 
signed an informed consent form that was 
approved by the Standing Committee for Ethics 




Fifty-six volunteers who attended the Chagas 
Disease Laboratory at the State University of 
Maringa (LDC/UEM) and Basic Health Units in 
Maringa were recruited for the study. The 
inclusion criteria were the following: individuals 
with Chagas disease (CHD group) without heart 
failure or with mild or moderate heart failure 
(New York Heart Association [NYHA] functional 
class I or II), individuals with mild to moderate 
systemic arterial hypertension (SAH - group), 
and normal individuals (NI - group) without these 
morbidities, and with stable clinical conditions. 
Participants of both genders, were included (35-
80 old). The exclusion criteria were the following: 
severe hypertension (SBP > 180 mmHg and 
DBP > 110 mmHg), decompensated diabetes 
mellitus, NYHA functional class III or IV 
congestive heart failure, cardiac pacemaker, 
chronic renal failure, pulmonary or pleural 
disease, musculoskeletal limitations or any other 
condition that would affect the ability to perform 
the functional tests. 
 
Participants were assessed for Chagas disease 
using indirect immunofluorescence and enzyme -
linked immunosorbent assay at the Teaching and 
Research Laboratory in Clinical Analysis 
(Laboratório de Ensino e Pesquisa em Análises 
Clínicas da Universidade Estadual de Maringá - 
LEPAC/UEM). They were also assessed by a 
cardiologist to perform treadmill exercise testing 
and determine the maximal and submaximal HR 
and intensity of physical exercise. 
 
The participants were divided into three groups: 
CHD (n = 16), SAH (n = 21), and NI (n = 19). The 
demographic characteristics and level of physical 
activity of the 56 participants are listed in Table 
1. The mean age was 63.2 ± 8.4 years old and 
75 % the participants were female. No significant 
difference in mean age was found between the 
CHD group and the other groups. No significant 
difference in the proportion of men was found 
between groups (p > 0.05). 
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Table 1: Demographics and level of physical activity of the 56 participants in CHD, SAH and NI groups subjected 
to the 6MWT and 12-week physical training program 
 
Variable CHD (n = 16) SAH (n = 21) NI (n = 19) 
Age  Mean  ±SD  Mean ±SD   Mean ±SD   
(years) 63.9 7.0 66.2 6.8 60.1 7.9 
       
Gender n % n % n % 
Male* 4 25.0 1 4.8 2 10.5 
Female 12 75.0 20 95.2 17 89.5 
       
Sedentary lifestyle       
Yes 6 37.5 0 0.0 0 0.0 
No  10 62.5 21 100.0 19 100.0 
CHD: Chagas disease, SAH: systemic arterial hypertension, NI: normal individuals, 6MWT: 6-min walk test. *p > 
0.05 
 
Six-minute walk test  
 
The 6MWT was performed according to the 
recommendations of the American Thoracic 
Association [12]. The 6MWT was always 
performed in the morning, between 8:00 AM and 
11:00 AM. The participants were instructed to 
walk as fast as possible for 6 min, without 
running, on a 30 -m long flat surface, without 
barriers traffic, from other people. The surface 
was marked every 1 m. Before starting the test, 
the volunteers were instructed about performing 
the test and its risks and benefits. All of the 
subjects were informed by the therapist 
regarding the elapsed time and received 
standardized verbal encouragement every 
minute. The intensity of verbal encouragement 
has been shown to affect the total distance 
traveled (i.e., the distance increases with more 
frequent and intense verbal encouragement) 
[12]. 
 
The participants were allowed to slow down, rest, 
or stop the test if necessary. If the participant 
stopped to rest, them they were instructed to 
resume walking as quickly as possible. If the 
participant stopped walking for some reason, 
then participant was placed in a chair and 
instructed to resume walking when possible [12]. 
After the end of the 6MWT, the distance traveled 
(in meters) and blood oxygen saturation were 
determined. The participant’s the subjective 
perceived exertion, was also assessed using the 
Borg scale: 0 (no exertion) to 10 (extreme 
exertion) [13]. 
 
The 6MWT was immediately discontinued if the 
participant experienced precordial chest pain, 
intolerable dyspnea, O2 saturation ≤ 85 %, 
muscle cramps, limping gait, malaise dizziness, 
or pallor. 
 
Determination of cytokine and nitric oxide 
levels 
 
The serum levels of cytokines were analyzed 
using a cytometric bead array (CBA) and 
determined according to the kit’s instructions 
(CBA Human Th1/Th2/Th17 Becton Dickinson) 
using a ACCURI C5 device (Becton Dickinson). 
The cytometry data were analyzed using "FCAP 
Array, 3.0.3, software (Soft Flow Hungary, Ltd."). 
Cytokine concentrations are expressed as pg/ml. 
We excluded participants whose cytokine 
concentrations were undetectable by the kit. Pro-
inflammatory cytokines [(IL-2, IL-6, IL-17, tumor 
necrosis factor-alpha (TNF-α), interferon-gamma 
(IF-γ)], inflammatory cytokines (IL-4, IL-10) and 
nitric oxide (NO), were are evaluated at 0, 6 and 
12 weeks (T0, T6, and T12 weeks)  in 12 
participants in the CHD group, 13 participants in 
the SAH group and 14 participants in NI group. 
Nitrite levels were used to estimate serum NO 
levels according to Panis et al [14]. 
 
Physical training program  
 
After performing the 6MWT and measuring 
cytokine levels at the beginning of the study (T0), 
the participants performed a 12-week aerobic 
physical training program, three times per week 
on alternate days. The exercise was of moderate 
intensity (70-80 % of maximum HR), with a 
gradual increase in duration each session up to a 
maximum of 1 h, based on the clinical condition 
of the patient. 
 
Initially, the participants performed muscle warm-
ups with active stretching of the upper and lower 
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limb, for 5 min, progressing to 10 min in the third 
training session. The aerobic phase of the 
exercise program was performed by walking for 
15 min, which progressively increased to 20 min 
in the second session and then to 30 min in the 
third session. At the end of each session, the 
participant was allowed to cool down, followed by 
10-min relaxation. The physical exercise program 
was conducted by a trained professional, in the 
morning, and outdoors, in a flat and shaded 
location. 
 
Systolic blood pressure (SBP), diastolic blood 
pressure (DBP), heart rate (HR) and blood 
oxygen saturation (SpO2), were evaluated at the 
beginning of the study (T0), and after 6 weeks 
(T6) and 12 weeks (T12) of physical training. 
Measurements were taken both pre- and post-
exertion. The SBP and DBP were measured on 
the left arm while each participant was in a sitting 
position. The measurements were taken using an 
indirect method and auscultation technique using 
a stethoscope and previously calibrated 
sphygmomanometer (Becton Dickinson). Heart 
rate was measured manually by palpation of the 
radial artery by a single evaluator. SpO2 was 




Intra-group differences at T0, T6 and T12 were 
determined using the Wilcoxon test. Differences 
between the CHD, SAH, and NI groups were 
compared using analysis of variance (ANOVA). 
Cytokine levels at T0, T6 and T12 were 
evaluated by one-way ANOVA, followed by 
Tukey’s multiple-comparison test. The data were 
analyzed using Prism 5.0 software (GraphPad, 
San Diego, CA, USA). The level of significance 




Table 2 shows the distance traveled in the 
6MWT, at the beginning of the study, and after 
12 weeks of physical training, which was not 
significantly different between groups. Intra-
group comparisons revealed a significant 
difference in distance traveled between the 
beginning of the study and after 12 weeks of 
physical training. All of the participants were able 
to complete the 6MWT without interruption. 
 
With regard to perceived exertion , indicated by 
the modified Borg scale, 43.7 % of the 
participants in the CHD group, 47.6 % of  the 
participants in the SAH group, and 52.6 % of the 
participants in the NI group reported no physical 
exertion (Borg scale = 0) at the end of the 6MWT 
at the beginning of the study. None of the 
participants reported maximum exertion (Borg 
scale = 10) the 6MWT at either the beginning of 
the study or after 12 weeks of physical training, 
with no significant inter- or intra- group 
differences (Table 2). 
 
At T0 the beneficial effects of exercise were 
already evident. The CHD and SAH groups 
exhibited a significant decrease in SBP (p = 
0.0017 and p = 0.0190, respectively), and 
significant increase in HR (p = 0.00001 and p = 
0.0048 respectively). The CHD and NI groups 
also presented significant improvements in 
oxygen saturation (p = 0.00005) (data not 
shown).  
 
At T6 pre exertion, CHD group exhibited a 
significant improvement in oxygen saturation and 
the SAH group exhibited a significant decrease in 
SBP (6.7 mmHg) (Table 3). 
 
Table 2: Distance traveled (in meters), and perceived exertion (according to the Borg scale) in participants with 
Chagas disease (CHD), and systemic arterial hypertension (SAH) and normal individuals (NI), in the 6-min walk 
test (6MWT) at the beginning of the study - 6MWT (1) and after the 12-week physical training - 6MWT (2). 
 
Variable 
 Group  
Beginning of 
study 
mean ± SD 
After 12 weeks of 
physical training 
mean ± SD 
P 
 CHD (n=16) 584.2 ±62.3 602.8 ±60.6 0.0084* 
Distance in 
6MWT(m) SAH (n=21) 585.0 ±75.6 610.5 ±75.8 
0.0011* 
 NI (n=19) 569.8 ±72.5 595.6 ±60.2 0.0023* 
        
 CHD (n=16) 1.4 ±1.8 1.4 ±1.5 0.7532 
Borg scale SAH (n=21) 1.4 ±1.5 2.0 ±1.2 0.1415 
 NI (n=19) 1.5 ±1.8 1.1 ±1.2 0.2367 
*p ˂ 0.05, significant difference (Wilcoxon test) SD: standard deviation 
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Between T6 and T12, the CHD group presented 
significant decreases in pre- and post-exertion 
SBP and pre-exertion DBP, and the NI group 
presented significant decreases in post-exertion 
SBP and DBP (data not shown). 
 
At T12, pre-exertion SBP significantly decreased 
in the CHD group (6.8 mmHg), SAH group (10 
mmHg), and NI group (5.8 mmHg; Table 3), and 
post-exertion SBP significantly decreased in the 
SAH group (7.1 mmHg) and NI group (5.2 
mmHg; Table 4). Pre- and post-exertion DBP 
significantly decreased in the SAH and NI groups 
(Tables 3 and 4). Significant improvements in 
pre-exertion oxygen saturation were observed in 
the CHD and NI groups (Table 3). 
 
Inter-group comparisons revealed a significant 
difference in SBP between the NI group and 
CHD and SAH groups at T0, T6 and T12. A 
significant difference in DBP was observed 
between the CHD group and NI group at T0, T6, 
and T12. A significant difference in HR was 
observed between the CHD group and SAH 
group at T0, T6 and T12 (data not shown).  
 
At T6, a significant increase in IL-10 levels was 
observed in the CHD group (p = 0.0207 Figure 
1). Between T6 and T12, IL-10 levels increased 
in all three groups, which also occurred at T12 
(CHD: p = 0.0022; SAH: p = 0.0010; NI: p = 
0.0015). Significant differences in the levels of IL-
2, IL-6, IL-17 and TNF -α were only observed in 
the NI group at T12 (Figure 1). In the CHD and 
SAH groups, IL-17 levels increased but not 
significantly. IFN-γ levels were not significantly 
different between groups at T0, T6 or T12. 
 
Table 3: Analysis of pre-exertion systolic blood pressure (SBP) and diastolic blood pressure (DBP), heart rate 
(HR) and oxygen saturation (SpO2) in participants with Chagas disease (CHD), and systemic arterial 
hypertension (SAH) and normal individuals (NI) at T0, T6, and T12  
  
Group Pré-exertion variable 
T0 
(mean ± SD) 
T6 
(mean ± SD) 
p T12 
(mean ± SD) 
P 
 SBP 130.6 16.1 128.8 11.5 0.3454 123.8 9.6 0.0366* 
CHD  DBP 82.5 9.3 81.9 8.3 0.7150 78.8 7.2 0.1097 
(n = 16) HR 67.1 11.9 68.1 7.9 0.6292 68.1 8.3 0.4412 
 %SpO2 96.9 1.5 97.3 1.1 0.0277* 97.3 1.0 0.0277* 
          
 SBP 133.8 12.8 127.1 13.5 0.0232* 123.8 12.0 0.0012* 
SAH DBP 81.4 7.3 79.0 9.4 0.2135 76.2 6.7 0.0033* 
(n = 21) HR 80.6 12.8 79.4 13.7 0.6219 79.5 14.6 0.6850 
 %SpO2 97.0 1.0 97.0 1.9 0.0744 97.0 0.7 0.5750 
          
 SBP 117.9 8.5 114.7 9.0 0.0587 112.1 9.8 0.0076* 
NI DBP 76.3 5.0 74.2 6.1 0.1775 72.1 7.1 0.0277* 
(n = 19) HR 76.4 12.3 73.4 9.2 0.5861 72.7 9.7 0.2944 
 %SpO2 97.2 1.1 97.8 0.9 0.0663 97.9 0.8 0.0033* 
* p ˂ 0.05, significant difference (Wilcoxon test). SD, standard deviation; T0, beginning of the study; T6, after 6 
weeks of physical training; T12, after 12 weeks of physical training 
 
Table 4: Analysis of post-exertion systolic blood pressure (SBP) and diastolic blood pressure (DBP), heart rate 
(HR) and oxygen saturation (SpO2) in participants with Chagas disease (CHD), and systemic arterial 
hypertension (SAH) and normal individuals (NI)at T0, T6, and T12 
 
Group Post-exertion variable 
T0 
(mean ± SD) 
T6 
(mean ± SD) 
p T12 
(mean ± SD) 
P 
 SBP 127.5 15.3 127.5 10.6 0.9326 123.8 9.6 0.1688 
CHD  DBP 81.9 9.8 81.3 7.2 0.7531 80.0 7.3 0.4008 
(n = 16) HR 80.4 13.0 81.5 12.2 0.6101 80.9 13.5 0.8657 
 %SpO2 97.9 1.2 97.9 1.2 0.9999 98.1 1.0 0.0678 
          
 SBP 129.0 13.0 124.8 12.5 0.0934 121.9 11.2 0.0035* 
SAH DBP 80.5 8.0 77.6 9.4 0.1955 75.2 6.8 0.0033* 
(n = 21) HR 85.8 15.7 83.0 15.7 0.1213 83.8 11.8 0.7323 
 %SpO2 97.5 1.2 97.8 0.8 0.2367 97.9 0.6 0.1744 
          
 SBP 116.3 6.8 116.3 9.6 0.9999 111.1 8.8 0.0076* 
NI DBP 75.3 5.1 75.3 5.1 0.9999 72.1 7.1 0.0277* 
(n = 19) HR 78.7 8.0 77.3 8.1 0.2665 75.6 9.6 0.0619 
 %SpO2 98.1 0.9 98.3 0.7 0.2367 98.4 0.8 0.0587 
*p ˂ 0.05, significant difference (Wilcoxon test). SD, standard deviation; T0, beginning of the study; T6, after 6 
weeks of physical training; T12, after 12 weeks of physical training 
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Inter-group comparisons revealed that serum IL-
10 levels were significantly higher in the CHD 
group compared with the SAH and NI groups at 
T0, T6, and T12. Serum IFN-γ levels were also 
higher in the CHD group compared with the SAH 
group at T0, T6, and T12 and compared with the 
NI group at T12. TNF-α levels were significantly 
higher in the CH group compared with the NI 






Figure 1: Serum levels of the cytokines IL-10 (A),  IL-2 (B), IL-6 (C), IL-17 (D),  TNF-α (E), INF-γ (F), 
in the groups with Chagas disease (CHD), and systemic arterial hypertension (SAH) and normal 
individuals (NI), at the beginning of the study  (T0), after 6 weeks (T6) and 12 weeks (T12) of physical 
training a p ˂ 0.05, significant difference between T0 and T6; bp ˂ 0.05, significantly different between 
T6 and T12; cp ˂ 0.05,  significant difference between T12 and T0 (paired Wilcoxon test for intragroup 
comparison), *p ˂ 0.05, significant difference (Wilcoxon test for intergroup comparisons). 
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Figure 2: Serum levels of nitric oxide (NO), in the groups with Chagas disease (CHD), and systemic arterial 
hypertension (SAH) and normal individuals (NI), at the beginning of the study (0), after 6 weeks (6) and 12 weeks 
(12) of physical training 
 
IL-6 levels were significantly lower in the NI 
group compared with CHD and SAH groups at 
T0, T6, and T12. No significant differences in IL-
2 or IL-17 levels were observed (data not 
shown). Physical training did not alter NO 




In the present study, the CHD, SAH, and NI 
groups performed the 6MWT before and after a 
12-week physical training program, to evaluate 
their performance and cardiopulmonary 
functional capacity. A significant increase in the 
distance traveled in the 6MWT was observed 
after the 12-week physical training program in all 
three groups, and most of the participants did not 
report physical exertion at the end of the test. 
These results demonstrated good performance in 
the 6MWT and improved functional capacity in 
the participants after regular 12-week moderate-
intensity physical training. 
 
Inter-group comparisons indicated no significant 
differences in the distance traveled in the 6MWT 
or perceived exertion. All of the participants had 
a good prognosis, in which they traveled a 
distance ≥ 350 m and were able to complete the 
test [15]. The good performance of the 
participants with CHD and SAH may be 
associated with NYHA functional classes I and II. 
Functional capacity and the distance traveled in 
the 6MWT in Chagas disease carriers are 
associated with the severity of cardiopathy [16]. 
These results indicate that the participants did 
not present functional impairment and thus had a 
lower risk of death because they were able to 
walk a longer distance than the considered cutoff 
value (522 m) for patients with CHD and heart 
failure  [16,17] and a longer distance than 
patients of both genders with mild SAH [1]. 
The 12-week physical training program 
significantly improved the participants’ blood 
pressure in the first exercise session at T6 and at 
T12. In the CHD and SAH groups, a significant 
reduction of SBP was observed in the first 
physical exercise session. According to Teixeira 
[19], after a single exercise session, blood 
pressure was decreased compared with prior 
values, and this decrease was maintained for an 
average of 1-2 h, thus characterizing a subacute 
response to exercise. This response begins 
immediately after the end of the exercise session 
and may last for 3-4 h. Decreases in the 
adrenergic response, cardiac output, post-
exertion plasma volume, and thermodilatation 
are subacute responses to exercise. The 
reductions of pre-exertion SBP in the SAH group 
at T6, pre- and post-exertion SBP and post-
exertion DBP in the CHD group between T6 and 
T12, and post-exertion SBP in the NI group 
between T6 and T12 are consistent with other 
studies that performed 6-10 week short term 
physical training [8]. 
 
At T12, reductions of pre and post-exertion SBP 
and in post-exertion DBP were observed, 
corroborating a previous study that conducted 
physical training for 12 weeks [8]. A significant 
decrease in pre-exertion SBP was observed in all 
three groups, and a decrease in pre-exertion 
DBP was observed in the SAH and NI groups, 
demonstrating the beneficial effects of physical 
exercise. Other authors also reported favorable 
effects of mild- or moderate-intensity exercise in 
reducing blood pressure in humans [8] and 
animals [9]. Such physical exercise induces 
structural cardiovascular remodeling, and is 
recommended for the prevention and treatment 
of SAH. Regular aerobic physical activity(e.g., 
walking) for at least 30 min three times per week 
reduces SBP by 4-11 mmHg, which returns to 
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pre-exercise values when physical activity is 
interrupted [20]. 
 
Reductions of DBP of only 2 mmHg can 
decrease the risk of comorbidities and mortality 
associated with hypertension, and physical 
exercise is indicated for patients with 
cardiovascular disease and mild cardiopathy. 
Such physical exercise has important health 
benefits. It lower risk factors, potentiates the 
efficacy of drug treatments, reduces the 
incidence of sudden death, improves quality of 
life, improves prognosis, and increases survival 
[20]. 
 
The pathogenesis of the chronic phase of 
Chagas disease is associated with host- and 
parasite, related factors, such as genetic 
constitution and the immune response. In the 
present study, the dynamics of IL-10 secretion 
were different in individuals with CHD, which was 
likely attributable to the parasite-host 
relationship. A significant increase in IL-10 levels 
was observed after 6 and 12 weeks of exercise 
in the CHD group. In the SAH and NI, groups, 
the increase in IL-10 levels was only observed 
after 12 weeks of exercise. Other authors have 
reported that  regular, long-term, moderate-
intensity physical training induces restorative 
stimulation of the immune system, including 
increases in antiinflamatory cytokines (e.g., IL-10 
and IL-4) and other cytokines (e.g., IL-5, IL-8, IL-
13, IL-15, IL-1ra, and tumor growth factor), which 
reduce the occurrence of infection [6,9]. The 
antiinflammatory cytokines IL-4 and IL-10 
attenuate the inflammatory response by 
decreasing the proinflammatory cytokines and 
suppressing monocyte activation. Moderate 
physical training improved the response to 
infection, decreased the parasite peak, and 
increased survival in mice that were infected with 
T. cruzi [9]. 
 
IL-10 is important in regulating the immune 
response, inflammatory response, and tissue 
damage, through its ability to “turn off" the 
production of inflammatory cytokines by T 
lymphocytes [21]. In the present study, serum IL-
10 levels were elevated in the CHD group. 
Elevations of this cytokine were also observed in 
asymptomatic patients, suggesting that IL-10 is 
part of a regulated immune response in patients 
without cardiomyopathy [21], and the presence of 
this cytokine is indicative of a good prognosis. 
Exogenous supplementation with IL-10 in 
Chagas disease can be useful for controlling 
myocarditis [22], in addition to controlling cardiac 
fibrosis. In the present study, regular moderate-
intensity physical exercise for 12 weeks 
significantly increased IL-10 levels in the CHD, 
SAH, and NI groups. 
 
Another interesting result was the significant 
difference in the serum levels of the 
proinflammatory cytokines IL-2, IL-6, IL-17 and 
TNF-α in the NI group after 12 weeks of physical 
training. These cytokines promote the activation 
of the inflammatory process, thereby eliminating 
pathogens, activating macrophages, Natural 
Killer cells, T cells, and B cells, and inducing 
immunoglobulin proliferation. We observed 
significant increases in IL-17 and IL-6 levels. IL-6 
is known as an “exercise factor”, that regulates 
the acute phase during physical exercise 
[7].Increases in IL-6 levels in response to 
physical exercise can play an antiinflammatory 
role, especially by inhibiting TNF-α production 
and stimulating the synthesis of antiinflammatory 
cytokines [7]. Increases in IL-17 levels were also 
observed in the CHD group. Individuals with 
Chagas heart disease have lower IL-17 
expression. High IL-17 expression is associated 
with better heart function and may be a 
protective factor in preventing myocardial 
damage in humans with Chagas disease [23]. 
 
Inter-group comparisons revealed elevations of 
IL-10 and IFN-γ levels in the CHD group 
compared with the SAH and NI groups. In the 
acute phase of infection, IFN-γ acts in concert 
with TNF-α to induce macrophage activation, and 
consequently NO production to eliminate the 
parasite [22,23]. In present study, the CHD, 
group had significantly higher TNF-α levels than 
the NI group at T12, which is consistent with 
other studies that reported high levels of TNF-α 
in patients with Chagas disease compared with 
healthy individuals [24]. The increase in TNF-α 
levels is related to the evolution of Chagas 
disease from the asymptomatic form to the 
symptomatic form, and is associated with the 
course and severity of chronic Chagas heart 
disease, suggesting its involvement in the 
formation of chronic inflammation and cardiac 
lesions [24]. 
 
Guedes et al. [25] reported that patients with 
moderate or severe cardiopathy had higher IFN-γ 
and TNF-α expression and lower levels of IL-10 
compared with patients with mild or no 
cardiopathy. Additionally, patients with a high risk 
of death exhibited lower levels of IL-10 and 
higher levels of IFN-γ, TNF-α, and inducible nitric 
oxide synthase, reflecting higher NO production, 
than patients with a low risk of death. In the 
present study, the immune response in 
participants with Chagas disease was 
significantly different from the other two groups, 
in which they presented elevations of IL-10 levels 
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and no increase in the production of NO, thus 
indicating a lower disease severity and lower risk 
of death. There are no markers that can predict 
the risk of developing cardiopathy in individuals 
with Chagas disease. The wide variation in the 
clinical course of this disease is attributable to 
complex host-parasite interactions. Symptomatic 
chronic infection induces an immune-type 
inflammatory response, with increases in the 
production of IL-2, IL-6, TNF-α, and IFN-α and 
decreases in the production of IL-4. 
Asymptomatic infection of an undetermined 
phase is characterized by a more regulated 
immune response, with higher production of 
antiinflammatory cytokines (e,g., IL-10 and IL-4), 
that promote the regulation of the immune 
response, prevent immunological damage and 
provide the persistence of T. cruzi in tissue[2]. 
 
Limitations of the study 
 
In the present study, no significant difference in 
IL-6 levels was observed between SAH and CHD 
groups. No significant difference in NO 
production between T0, T6, and T12 was 
observed in any of the groups, including the CHD 
group that presented the highest NO levels at all 
times tested compared with the other groups. 
This lack of observed differences may be 





Regular moderate-intensity exercise is important 
for improving quality of life, by reducing blood 
pressure, preventing coronary and autoimmune 
disease and stimulating the production of 
antiinflammatory cytokines (e.g., IL-10). The 
CHD group presented good performance in the 
6MWT, in which they did not present a significant 
difference in distance traveled or perceived 
exertion compared with the SAH and NI groups.  
Significant decreases in SBP and DBP and a 
significant increase in antiinflammatory IL-10 
levels were observed in all three groups after 12 
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